Aligned to Global Landscape

The Global Dermatology market was valued at $20.0 billion in 2015, and is projected to reach $33.7 billion in 2022 growing at a considerable Compound Annual Growth Rate (CAGR) of 7.73%, while Indian Dermatology Market is estimated at $ 925 million with a Compound Annual Growth Rate (CAGR) of 21%.

 

The Dermatology practice management industry remains fragmented and ripe for consolidation. Dermatological conditions are one of the most common types of disorders worldwide.

 

The landscape is expected to change substantially with the advent of promising novel pipeline products, largely skewed towards Cosmeceuticals like Sunscreen, Anti-aging, Skin Brightening (Depigmenting), Hair Serums / Tonics and Emollients in India and worldwide.

 

The different skin conditions and diseases which impact millions of people worldwide, can have significant, multidimensional effects on patients’ quality of life, including their physical, functional and emotional well-being.

Our Commitment

According to multiple published studies, patients report that Dermatology conditions affect their quality of life in ways comparable to other serious diseases.

 

Increased access to Dermatologists, greater health awareness and favorable demographic trends are driving demand for Dermatological Services.

 

We at Regaliz India are committed to bring innovative and differentiated products to Dermatologists and their patients for the treatment of these highly prevalent conditions and poised to recuperate their Quality of Lives.

 

 

 

 

 

 

 

 

Our major Therapeutic segments

Emollient / Moisturizer

Sunscreen

Anti-acne

Skin Brightening (Depigmentation)

Anti-aging

Trichology

Anti-fungal

Corticosteroids

We gradually intend to bring to India other Novel Products of different Therapeutic segments from our existing huge Product Range.

newsletter

Submitting Form...

The server encountered an error.

Form received.